glomerulonephritis / vasculitis dr catherine wall amnch 2009
TRANSCRIPT
Glomerulonephritis / Vasculitis
Dr Catherine Wall
AMNCH
2009
Glomerular Filtration
Afferent arteriole Efferent arteriole
Glomerulus
Angiotensin II - efferent arteriolar vasoconstriction
Filtrate
Filtration Barrier
endothelium
GBM
epithelium
Type IV collagen
BLOOD
URINE
Sub-endothelial space
Sub-epithelial space
Normal Urine Protein
• Upto 150mg / 24 hours in adults– 300mg in children / adolescents– Generally 50% filtered
Albumin / Immunoglobulin
Light chains / B2M
50% secreted
Tamm Horsfall protein (TALH)
• Transiently increased– Fever / heavy exercise / infection / CCF / orthostatic
Proteinuria
• Glomerular– Heavy proteinuria highly suggestive glomerular lesion– Typically nephrotic range– ‘High Selectivity’ – implies mainly albumin – gen MCD
• Tubular– Typically 1-2g of protein (sub nephrotic)
– Usually due to failure to reabsorb small molecular weight proteins e.g. B2 Microglobulin
• Overflow– Haemoglobin / myoglobin– Light chains – myeloma – not detected by Dipstix
Detecting Proteinuria
• Urine dipstick– Primarily detects albumin > 300-500mg / day– Will not detect Light chains (BJP)
Microalbuminuria
• Quantitation– 24 hour urine inaccurate / incomplete collection
poor patient compliance
– Protein / creatinine ratio (PCR) – general clinic– Diabetics ACR / Micral stix
Protein creatinine ratio • Spot urine protein:creatinine ratio works
well (especially if morning urine) - no need for 24 hour collections
Protein/creatinine mg/mmol g/24 hours
<20 <0.15
120 1
400 3.5
1200 10
(for SI units: just divide by ~100 !)
Microalbuminuria
• Protein excretion above normal but below the threshold of “Standard Dipstick”– Albuminuria normally <20mg/24 hrs (15 µg/min); – Microalbuminuria = 30-300mg/24 hrs (20-200 µg/min)
• Albumin-to-creatinine ratio
– microalbuminuria = 2.5 - 3.5 mg alb/mmol creatinine
• Risk factor in Diabetic Nephropathy• High incidence of false positives
Microalbuminuria Early marker of Diabetic Nephropathy
Usually develops within 10 years of onset of DM• Duration of disease before onset of Microalbuminuria
correlates with risk of progression to nephropathy– Microalbuminuria < 10 years - Most progress – Microalbuminuria > 10 years 30 -50 % progress
Outcome much better than original studies –
?effect of active Rx
Diabetic nephropathy
Stage GFR 24 hr albumin
Description Urine dip Micral
I Normal N inc < 30 Normal Negative Negative
II Incipient Inc N 30 - 300 Microalbuminuria Negative Positive
III Overt N dec > 300 Macroalbuminuria Positive Positive
IV ESRD > 3000 Nephrotic Positive Positive
Dipstick Urinalysis – Haematuria• Dipstick urinalysis detects Haem protein
– either red blood cells or Hb or myoglobin) – Highly sensitive but many false positive tests– Confirm with urine microscopy. – Transient haematuria is relatively common in
young subjects and is not indicative of disease.
Negative tests reliably excludes abnormal haematuria
Discoloration of urine
• Rifampicin orange
• Beetroot red
• Rhabdo smoky brown
• Black alkaptonuria
• Red / brown co-danthramer
• Blue methylene blue / amitrip
Urine Microscopy
• Hyaline casts normal• Fine granular casts normal• Coarse granular casts proteinuria• Muddy brown casts ATN• White cell casts AIN / pyelo• Red cell casts vasculitis / crescentic
GN• Crystals• Oval fat bodies nephrotic syndrome
Autosomal Dominant Polycystic Kidney Disease
• 2 Types PKD 1 85% Chr 16PKD 2 15% Chr 4
• 25% spontaneous mutations
• Prevalence 1 : 500 - 1 : 1000 (Europe)
8 - 10% of dialysis patients• Sex Males = Females
• Clinical onset Typically 20’s - 50’s
Polycystic Kidneys
Pathophysiology
• Disease begins in utero
• Cysts can arise anywhere along the nephron– only 1 - 5% of nephrons are involved
• Intervening areas show nephrosclerosis and chronic interstitial nephritis
• Typically 1-2 g proteinuria only (tubular)
Clinical Features / Associations
• Abdo pain / macro haem / cyst infection / stone / rupture
• No inc risk of RCC in cysts• Cysts –
– pancreas (<10%) – no panc failure– liver (50-90% - F>>M) – no liver failure
• Cardiac – MVP / AI / hypertension• Diverticular disease• Polycythaemia / anaemia• Berry aneurysms – 5%
Renal failure“50% by age 70”
• Progresses to ESRF in about 10yrs once serum creatinine rises above normal
• Rate of progression of CRF usually similar in families
Progression is faster with- PKD1:Median age of ESRF = 56 years- PKD2:Median age of ESRF = 68 years - high BP - gross haematuria- proteinuria - pregnancy - male sex - larger kidneys
Subarachnoid HaemorrhageRisks & Prevalence overestimated• Berry aneurysms
– 4% young adults rising to 10% in elderly– 65% risk of rupture
• Tend to cluster in families • Prevalence in asymptomatic patients is felt to be
lower• Role of screening controversial
Risk of hypertensive stroke or intracerebral haemorrage is still 10x higher than risk of subarachnoid
GENETICS 2 genes involved
PKD 1
• Short arm of chr 16
• Encodes polycystin 1 - ? adhesion
PKD 2
• Long arm of chr 4• Encodes polycystin 2
- ? cation channel
DIAGNOSIS Ultrasound• Very sensitive and specific
– Especially in Patient > 30 years of age– Detects cysts as small as 1 - 1.5 cm– Increased false negatives in young patients– multiple cysts in both kidneys which are large
• CT (with contrast )• More sensitive than USS
– Detects cysts of 0.5cm– Definitive radiological test
• Genetic screening – not available
CT Scan APKD
Glomerular Disease
Primary
Minimal changeMembranous GNFSGSMesangioproliferative GNIgARenal limited crescentic GN
Secondary
Metabolic DM HbSImmunologic SLE
MCGNCrescentic
GNHSP
Drugs NSAIDS etcInfectionsParaproteins / NeoplasiaAlportsPregnancy related
Dept. of Renal Medicine, St. James's Hospital.
Major Clinical Syndromes of Glomerular Disease
• Nephrotic Syndrome
• Nephritic syndrome
• Rapidly Progressive Glomerulonephritis
• Chronic Glomerulonephritis
• Persistent urinary abnormalities with no symptoms
Nephrotic Syndrome
• Proteinuria > 3.5g in 24 hours• Hypoalbuminaemia < 30g/dL• Oedema• Hyperlipidaemia / lipiduria• Hypercoagulable state• Hypogammaglobulinaemia
• Loss of Vit D BG / Vit D – osteomalacia• Loss of EPO / transferrin – anaemia• Loss of TBG – low T4 but N TSH ie euthyroid
Investigations – Nephrotic Syndrome
• Biochem / Haem / endocrine
• Urine
• Immunology
• Radiology
Case 1
• 47 year old male with DM2 for 7 years on oral hypoglycaemics, he has no retinopathy. BP is 125/75mmHg. He has severe rheumatoid arthritis for over 25 years. He developes ankle swelling and is found to have 4+ protein on dip
– Creatinine 98umol/l (eGFR 79mls/min)– HbA1C 6.4%– Alb 22mg/dl Chol 8.9– Urine protein 8g / 24hrs
Case 1• What renal condition is present?• What other information would you like?
• Suggest potential likely causes based on the history
• What investigations would you perform?
Case 1
• You discover that he has taken gold and penicillamine in the past as DMA. He takes NSAIDS daily.
• Suggest alternate diagnoses?
• His renal US is normal. He admits to weight loss and a non-productive cough for over 6 months. He is a lifelong smoker. CXR identifies a suspicious lesion.
• How will you investigate this man further ?
Case 2• A 34 year old woman presents with weight loss,
intermittent fevers and joint pains for 6 months. On examination her BP is 158/95mmHg, she has swollen joints and a L pleural rub.– Urea 18 Glucose 4.8– Creatinine 259 Urine 3+ blood and protein– Albumin 16 PCR 1080– ESR 108
– Urine microscopy red cell and granular casts
Case 2• Suggest appropriate initial investigations.
• Suggest a unifying diagnosis
Case 2• She is ANA and dsDNA strongly positive. Her
complements are reduced and she is anticardiolipin Ab positive – what is the diagnosis?
• Her creatinine rises to 450umol/l overnight and she developes severe L loin pain and frank haematuria, suggest a differential and relevant investigations.
Classes of Lupus Nephritis
• Class I normal• Class II mesangial• Class III focal proliferative GN• Class IV diffuse proliferative GN• Class V membranous• Class VI sclerotic
• Hallmark full house immunology
Nephrotic Syndrome due to Primary Glomerular Disease
< 15 yr > 15 yr
Minimal change 80% 28%
Membranous 1% 25%
Mesangiocapillary 8% 12%
FSGS 7% 15%
Proliferative 4% 20%
Minimal Change Disease
• Presentation– Nephrotic syndrome (selective proteinuria)– Acute renal failure (typically ATN)
• Treatment (frequently relapses)– Steroids– Cyclophosphamide/chlorambucil– Cyclosporin A– Levamisole
T
G
I
Membranous GN
• Idiopathic M < F, 5th decade onwards
• Neoplasia bowel / breast / bronchus
• Infection Hep B / C / syphilis• Drugs Penicillamine• SLE Type V lupus nephritis• Disease of ‘thirds’• Rx – controversial
• Subepithelial deposits with spikes
Membranous nephropathy
• 1/3 remit spontaneously• 1/3 progress to ESRF• 1/3 no change
Granular C3 and IgG on basement
membrane
Focal Segmental Glomerulosclerosis
• Presents with nephrotic syndrome in 75%• Secondary FSGS consequent on glomerular
scarring– IgA Nephritis Post vasculitis reflux – Sickle cell disease Alport’s disease
• Histology - focal & segmental sclerosis, no ICS
• Can recur in renal Tx - 23% ~ graft loss 10%
Focal Segmental Glomerulosclerosis
• Collapsing Variant– Explosive onset NS with renal failure
• Causes– HIVAN – Tx HAART / ACEi– Pamidronate– Heroin– Idiopathic– Parvovirus B19
MesangioCapillary GN -MCGN(Membranoproliferative GN)
• Presentation - Nephrotic (50%) - Nephritic (25%)• Histologically Type 1 - Subendothelial deposits
Type 2 - Dense deposit disease• Associated with low complement levels
– C3 nephritic factor– Partial lipodystrophy
• No treatment shown to be effective– 50 % ESRF at 10 years– Can recur in renal Tx - 25% ~ graft loss 10%
Dept. of Renal Medicine, St. James's Hospital.
Acute Poststreptococcal Glomerulonephritis
• Principally a disease of children (M>F)• Characteristic 10 day latent period between sore
throat and renal disease• Urine - ‘Smoky Brown’ haematuria
- oliguria, ARF• Dx -
– rising ASO titre, low C3 – throat culture - streptococcal A– renal biopsy – subendo deposits, proliferative lesion
IgA Nephropathy
• Synonym - Berger's Disease– Commonest primary glomerulonephritis– Increased incidence in the Far East
• Unknown aetiology– IgA dysregulation / Viral aetiology– IC disease – mesangial C3 / IgA on biopsy– 50% have raised IgA
• HSP – IgA + vasculitic rash buttocks etc
IgA Nephropathy• Associations
– Cirrhosis– Dermatitis herpetiformis / Gluten enteropathy– Mycosis fungoides
• Presentation / Outcome– Microscopic / macro haematuria (synpharyngitic)– Proteinuria / NS– RPGN with crescents– 20% ESRF at 20 years
• Treatment– Controversial. Some patients may benefit from
steroids, fish oils or MMF.
Vasculitis
Determinants of Clinical Manifestations
• Target organ involved
• Size of blood vessel involved
• Pathobiology of inflammatory process of involved vasculature
Sequelae of Vasculitis
• Vasculitis is a primary inflammatory process of vasculature
• Stenosis / occlusion of involved vessels resulting in organ ischaemia or infarction
• Necrosis of vessel walls– Aneurysmal dilatation and / or thrombosis– Causing organ ischaemia / infarction / haemorrhage
Crescentic Glomerulonephritis
Crescentic GN
• Immune complex mediated– Widespread immune deposits eg SLE / MPGN
• Linear Ig deposition– Typical of anti-GBM disease
• Pauci-immune– Absence of immune deposits– Classical for ANCA assoc vasculitis
Pauci-immune Crescentic GN
Anti-GBM mediated Crescentic GN
Immune Complex mediated Crescentic GN
Wegener’s Granulomatosis
• Necrotising vasculitis of arterioles / capillaries / post capillary venules– Associated with ANCA antibodies– Characterised by non-caseating granulomata on
biopsy
• Triad of clinical manifestations– Upper respiratory tract involvement– Lower respiratory tract involvement– Crescentic GN
Wegener’s Granulomatosis – ENT Disease
• Chronic sinusitis
• Chronic otitis
• Epistaxis
• Nasal crusting
• Destruction nasal cartilage – saddle nose
• Hoarseness
• Tracheal stenosis
Wegener’s Granulomatosis – ENT Disease
Wegener’s Granulomatosis – Lung Involvement
Wegener’s Granulomatosis – Skin Involvement
Wegener’s Granulomatosis – Mononeuritis Multiplex
ANCA positive vasculitis
Wegener’s, microscopic polyarteritis, Churg-Strauss syndrome, renal limited
Rapidly progressive ARF
Haemoptysis,
Anti-MPO/anti PR3 antibodies
Emerging Role of ANCA
• ANCA background– Identified in 1980s, marker of disease
– Useful for confirming diagnosis, predicting relapse, reposnse to therapy etc
– Autoantibodies directed against neutrophil cytoplasmic antigens
• C-ANCA antigen Proteinase 3• P-ANCA antigen usually MPO
P-ANCA
Antigen:
Myeloperoxidase
C-ANCA
Antigen:
Proteinase-3
Are ANCA Pathogenic?
• Compelling in vivo evidence emerging• Murine models
– Transfer of anti-MPO causes pauci-immune vasculitis– Transfer of anti-PR3 causes skin inflammation at site
of TNFa administration
• WKY rat immunised with human MPO (Little et al)
– Developes anti-MPO antibodies– Developes crescentic GN and lung vasculitis– Neutrophils show enhanced adhesion / transmigration
on intravital microscopy of mesenteric venules
Treatment of Wegener’s Granulomatosis
• Immunosuppression– Methylprednisolone / steroids– Cyclophosphamide – MMF or AZA maintenance (relapse+++)
• Plasma Exchange– Pulmonary haemorrhage– Severe renal failure
Goodpasture’s
• Mediated by anti GBM antibody directed against basement membrane of kidney / alveolus
• Goodpasture’s Disease– Crescentic GN
• Goodpasture’s Syndrome– Crescentic GN– Alveolar haemorrhage
Goodpasture’s
• Exceedingly rare– 1 case per million per annum
• Male preponderance– Young males / 2nd peak in 5-6th decade– Smokers / exposure to hydrocarbons
• Uniformly fatal without treatment– No recurrence following recovery
• Ab directed against alpha III chain of Type IV Collagen (Alport’s Ag)
Goodpastures
Anti-GBM disease
Treatment
Steroids
Plasma exchange
Cyclophosphamide
Case 1
• A 40-year-old garage mechanic presents with a 3-month history of generalised malaise, decreased appetite, fever, cough, intermittent haemoptysis and increasing shortness of breath. He is a life long non-smoker.
• What other history would you like to obtain from this gentleman?
• What is your differential based on the history?
Relevant HistoryWeight loss / other constitutional symptoms
Nature of haemoptysis: streaky / clots / amount
Quantify SOB / diurnal variation etc
Wheeze / hoarseness / CP (inc pleuritic) / epistaxis
PND / orthopnea / ankle swelling
Haematuria / altered urine output / uraemic symptoms
Skin rashes / joint problems / neuro
Family history: thrombophilia / autoimmune disease / TB
Social history: occupational exposure / foreign travel / hobbies
Physical Findings
Exam: Pale, unwell looking, sats 93% RA,
BP 160/95, RR 30, pulse 110
CVS normal
RESP coarse creps both lung bases
Mild pedal oedema
Skin / joints normal
Urinalysis: Proteinuria 3+ Blood 3+
Urine microscopy: Dysmorphic red cells
Red cell casts
Results 1
FBC Hb 8.7 g/dlWCC 10.5 x 109 /lPlt 350MCV / film normal
Coag normalBio Urea 22 mmol/l
HCO3 18 mmol/lCreatinine 450 umol/lAlbumin 29 mg/dlK 5.3 mmol/lCa (corr) 1.98 mmol/lNa 138 mmol/lPO4 2.01 mmol/l
What initial investigations would you perform?
Results 2
ABG’s pH 7.33
PO2 9.5 kPa
PCO2 3.3 kPa
HCO3 19 mmol/l
Sats 94%
Sputum culture: Negative including Zn / TBC
Sputum cytology: Negative for malignant cells
CXR: diffuse bilateral alveolar shadowing
What is Your Differential Now?
What is Your Differential Now?
Wegener’s granulomatosis
Microscopic polyangiitis
Churge-Strauss syndrome
Goodpasture’s syndrome
What Other Investigations Will You Order?
What Other Investigations Will You Order?
Immunology ANA / RF / Cryoglobulins negativeC3 / C4 normalSPEP / UPEP normalANCA negativeAnti-GBM 93% (highly positive)
PFTs Actual PredictedFEV1 2.6 3.0FVC 2.9 4.2TLC 5.1 6.5KCO 2.8 2.2
Renal US
• What is the likely diagnosis?
• How might you treat this patient?
• What is his prognosis?